- For U.S. Healthcare Professionals only
- Patient Site
- Indications
Indication
AUGTYRO® (repotrectinib) is indicated for the treatment of adult patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC).
- U.S. Full Prescribing Information
- Patient Information
- Patient Site
REQUEST A REP
